Angiotensin receptor antagonists: focus on losartan

This publication has 17 references indexed in Scilit:

• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
  The American Journal of Cardiology, 1995
• Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients
  Hypertension, 1995
• Hemodynamic and Biochemical Effects of the AT ₁ Receptor Antagonist Irbesartan in Hypertension
  Hypertension, 1995
• Characterization of the Angiotensin II Receptor Antagonist TCV-116 in Healthy Volunteers
  Hypertension, 1995
• Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?
  Kidney International, 1994
• Comparison of Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human Forearm
  Journal of Cardiovascular Pharmacology, 1993
• Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
  Hypertension, 1993
• Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
  Hypertension, 1993
• Dose-Ranging Study of the Angiotensin Type I Receptor Antagonist Losartan (DuP753/MK954), in Salt-Deplete Normal Man
  Journal of Cardiovascular Pharmacology, 1993
• Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
  Journal of Clinical Investigation, 1993